India to United Arab Emirates: Ketorolac Export Trade Route

The India to United Arab Emirates Ketorolac corridor is one of India's established pharmaceutical export routes, with 114 shipments documented worth a combined $747.2K USD. The route is dominated by SCOTT EDIL PHARMACIA LIMITED, which alone accounts for roughly 64% of all export value, reflecting the consolidated nature of India's ketorolac manufacturing sector.

Across 28 active suppliers, the average shipment value stands at $6.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with ketorolac's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 26.9%, placing it at rank #2 among India's top ketorolac export destinations globally.

On the import side, key buyers of Indian ketorolac in United Arab Emirates include TO THE DIRECTOR OF, DIRECTOR OF MEDPHARM, TO THE ORDER OF and 22 others. TO THE DIRECTOR OF is the single largest importer with 2 shipments valued at $321.0K USD.

India's ketorolac exports to United Arab Emirates are driven primarily by a handful of large-scale manufacturers. SCOTT EDIL PHARMACIA LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 28 active exporters signals a competitive but concentrated market — buyers in United Arab Emirates benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SCOTT EDIL PHARMACIA LIMITED, AMARI TRADE ALLIANCE LLP, LAZERHEAD LIFESCIENCES PRIVATE LIMITED — together account for 83% of total trade value on this route. The average shipment value of $6.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless pharmaceutical medicines finished formulation ketorolac tromethamine inj,30mg/ml and harmless pharmaceutical medicines finished formulation ketorolac tromethamine inj30mg/ml, suggesting that buyers in United Arab Emirates tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE DIRECTOR OF is the largest importer with 2 shipments worth $321.0K USD — representing 43% of all ketorolac imports from India on this route. A total of 25 buyers are active on this corridor.